Welcome to
The Fetal Medicine Foundation Germany!

Goals and Responsibilities
Information Material
Press Review
Privacy policy
The FMF-Germany is a registered charitable organisation composed of specially trained colleagues (prenatal diagnosticians), human geneticists and laboratory physicians. It aims at providing all interested pregnant women in their first third of pregnancy with a standardised tool for prenatal diagnosis which goes beyond the usual prenatal care measures and which is capable of meeting the highest possible quality requirements.
Prof. Dr. E. Merz
Prof. Dr. E. Merz
This non-invasive early screening method consists of a focused ultrasound examination of the fetus between the 11th and 14th week of pregnancy. It involves the measurement of so-called "nuchal translucency" and the collection of a maternal blood sample for detection of free beta-hCG and PAPP-A (pregnancy-associated plasma protein-A). A special computer programme then assesses the individual risk of chromosome abnormality. It enlightens not only about the possibility of a chromosomal disorder, but also informs about the risk of any other fetal anomaly.
The high quality of examination demanded by the FMF-Germany is ensured at all times because only those colleagues are approved as examiners who have successfully completed a theoretical and practical examination at an FMF-certified training centre and who will submit to regular quality control reviews in 12-month time intervals. The same applies to all laboratories certified by the FMF-Germany. Laboratories undertake to apply FMF-approved measurement procedures only, and to participate in international interlaboratory trials.
All colleagues concerned with prenatal diagnosis are greatly welcomed to share in the voluntary quality concept of the FMF-Germany.
Prof. Dr. E. Merz
First President of the FMF-Germany